Anaesthetic agents in neuromuscular disorders
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Anaesthetic agents in neuromuscular disorders. Use regional anesthesia whenever possible. Fully referenced neurology checklist.
General anaesthetic principles
- Use regional anesthesia whenever possible
- Consider total intravenous aneasthesia (TIVA)
- Sedation and aneasthesia must be done in facilities with 24-hour care
- Schedule neuromuscular patients as the first cases of the day
- Consider the use of Suggamadex
- Consider the perioperative risk of non-anaesthetic drugs
Anaesthetic risk considerations: sedatives
Locked: subscribe to see this section.
Anaesthetic risk considerations: others
Locked: subscribe to see this section.
Medical risk considerations
Locked: subscribe to see this section.
References
- Racca F, Mongini T, Wolfler A, et al. Recommendations for anesthesia and perioperative management of patients with neuromuscular disorders. Minerva Anestesiol 2013; 79:419-433.
- Katz JA, Murphy GS. Anesthetic consideration for neuromuscular diseases. Curr Opin Anaesthesiol 2017; 30:435-440.
- Baur CP, Schlecht R, Jurkat-Rott K, Georgieff M, Lehmann-Horn F. Anesthesia in neuromuscular disorders. Part 1: introduction. Anasthesiol Intensivmed Notfallmed Schmerzther 2002; 37:77-83.
- van den Bersselaar LR, Heytens L, Silva HCA, et al. European Neuromuscular Centre consensus statement on anaesthesia in patients with neuromuscular disorders. Eur J Neurol 2022; 29:3486-3507.
- Sinclair JL, Reed PW. Risk factors for perioperative adverse events in children with myotonic dystrophy. Paediatr Anaesth 2009; 19:740-747.
- And 2 more. Subscribe to see the full list
